⌘K

Login Start Free

Home/Filings/4/0001493152-21-009073

4//SEC Filing

Lotz Christopher L. 4

Accession 0001493152-21-009073

CIK 0001460702other

View on SEC.gov Company Profile

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 6:15 AM ET

Size

4.6 KB

Accession

0001493152-21-009073

Insider Transaction Report

Form 4

Period: 2021-04-16

Qualigen Therapeutics, Inc.QLGN

Lotz Christopher L.

VP of Finance, CFO.

Transactions

Purchase
Common Stock
2021-04-16$1.86/sh+2,700$5,022→ 12,541 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Qualigen Therapeutics, Inc.

CIK 0001460702

Entity typeother

Related Parties

1

filerCIK 0001812553

Filing Metadata

Form type: 4
Filed: Apr 18, 8:00 PM ET
Accepted: Apr 19, 6:15 AM ET
Size: 4.6 KB

View on SEC.gov